Fundraising Fox

BioRegenx

OTC: BRGX

Chattanooga, US · Founded 2021 · Nevada corporation

bioregenx.com ↗

BioRegenx is a health-technology holding company developing and acquiring patented regenerative biotherapeutics, anti-aging nutraceuticals, and AI-based health monitoring tools, including non-invasive microvascular imaging (GlycoCheck), a plant-based supplement (Endocalyx Pro), and contactless vital-sign analysis (DocSun). It sells through direct-to-institution, direct-to-practitioner, and direct-to-consumer models across the health, wellness, and longevity market.

AI & Machine LearningBiotechHealthtechLongevity

Founders & leadership

HV
Hans VinkExecutive Officer, Director, Promoter
WR
William ResidesExecutive Officer, Director, Promoter
RL
Robert LongExecutive Officer, Director, Promoter
GH
Gary HennerbergExecutive Officer, Director
HJ
Hitesh JunejaExecutive Officer
SA
Sherri AdamsDirector
SB
Suzanne BirdDirector
JW
Jody WalkerDirector

Competitors · 2

by search overlap
Regenx Biosciences12 shared keywordsREGENXBIO is a biotechnology company developing gene therapies for patients. Its work centers on treatments aimed at addressing serious diseases affecting patients and their families.
Mapquest7 shared keywordsProvider of geographical information systems and services; acquired by America Online.

Companies competing with BioRegenx for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
▶$183KraisedApr 2023 · 5 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph S BirdPromoter
  • Robert DoranPromoter
  • Sherri AdamsDirector
  • Suzanne BirdDirector
  • Hans VinkExecutive Officer, Director, Promoter
  • William ResidesExecutive Officer, Director, Promoter
  • Robert LongExecutive Officer, Director, Promoter
  • Jody WalkerDirector
  • Gary HennerbergExecutive Officer, Director
  • Hitesh JunejaExecutive Officer
Offering amount
$3.6M
Amount sold
$183K
Proceeds to insiders
$150K
First sale
Jan 2023
Incorporated
Corporation, Nevada, 2021
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$615.5KraisedAug 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William ResidesExecutive Officer, Director, Promoter
  • Robert LongExecutive Officer, Director, Promoter
  • Gary Dale HennerbergExecutive Officer, Director, Promoter
  • Hans VinkExecutive Officer, Director, Promoter
  • Robert DoranExecutive Officer, Director, Promoter
  • Joseph Simmons Bird, Jr.Executive Officer, Director, Promoter
Offering amount
$3M
Amount sold
$615.5K
Proceeds to insiders
$945.9K
First sale
Jul 2021
Incorporated
Corporation, Nevada, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.